Research programme: prostaglandin analogues - AlconAlternative Names: AL-12182; Prostaglandin analogues research programme - Alcon
Latest Information Update: 02 Jul 2007
At a glance
- Originator Alcon
- Mechanism of Action Prostaglandin agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Glaucoma
Most Recent Events
- 02 Jul 2007 Discontinued - Preclinical for Glaucoma in USA (unspecified route)
- 06 Sep 2004 Preclinical trials in Glaucoma in USA (unspecified route)